| Short-term Outcomes in Infants after General Anesthesia with Low-dose Sevoflurane/Dexmedetomidine/Remifentanil versus Standard-dose Sevoflurane (the TREX Trial).Anesthesiology | PMID 39283983无 PMCID | 2024-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| The impact of mepolizumab on sleep impairment in CRSwNP: post hoc analyses of SYNAPSE and MUSCA.Rhinology | PMID 39323188无 PMCID | 2024-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks.JAMA Dermatol | PMID 39441580PMC11581505 | 2024-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial.JAMA Oncol | PMID 39480453PMC11528341 | 2024-Dec-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 已完成 |
| Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents.J Drugs Dermatol | PMID 39630680无 PMCID | 2024-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Efficacy and Safety of Nefecon in Patients with IgA Nephropathy from Mainland China: 2-Year NefIgArd Trial Results.Kidney360 | PMID 39724565PMC11687989 | 2024-Dec-01 | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma: A phase III bridging study in Chinese patients.J Cancer Res Ther疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。 | PMID 39792424无 PMCID | 2024-Dec-01 | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 无 KM 图 |
| Efficacy and Safety of Topical Solution of Diperoxochloric Acid for Neuropathic Diabetic Foot Ulcer: Results from a Phase 3, Multicentre, Randomized, Active-controlled, Parallel-group Study.Int J Low Extrem Wounds | PMID 35275009无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Metoclopramide Nasal Spray in Women With Symptomatic Diabetic Gastroparesis: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.Clin Gastroenterol Hepatol | PMID 37924856无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| The Efficacy of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Phase 3 Randomized Placebo-Controlled Clinical Trial.Clin Gastroenterol Hepatol | PMID 38237696无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| A Study of Safety and Effectiveness of Evicel Fibrin Sealant as an Adjunctive Hemostat in Pediatric Surgery.Eur J Pediatr Surg | PMID 38552641PMC11537722 | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.Eur Urol Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。 | PMID 38582650无 PMCID | 2024-Dec | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 无 KM 图 |
| Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials.J Dermatolog Treat | PMID 38632977无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Lebrikizumab monotherapy impacts on quality of life scores through improved itch and sleep interference in two Phase 3 trials.J Dermatolog Treat | PMID 38679419无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up study.J Dermatolog Treat | PMID 38697950无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.J Dermatolog Treat | PMID 38735650无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Comparison of Los Angeles Grades of Erosive Esophagitis Scored by Local Investigators vs Central Adjudicators in a Clinical Trial.Clin Gastroenterol Hepatol | PMID 38777170无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial.Emerg Microbes Infect | PMID 38860446PMC10906127 | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians.J Dermatolog Treat | PMID 38880494无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Supplemental Intravitreal Ranibizumab Injections in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial.Ophthalmol Retina | PMID 38914294无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III Study.Ophthalmol Retina | PMID 38942386无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials.J Dermatolog Treat | PMID 38945549无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial.Am J Obstet Gynecol | PMID 38955323无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Adjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010.Eur Urol Oncol | PMID 38955577无 PMCID | 2024-Dec | 0.96 | 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 | 待处理 |
| Hormone-related side effects in new users of a levonorgestrel 52-mg intrauterine device.Am J Obstet Gynecol | PMID 38969201无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial.Cannabis Cannabinoid Res | PMID 39016024PMC11685298 | 2024-Dec | 0.85 | The study is an oncology-related randomized trial with a drug intervention and reports original results, but it is explicitly a pilot trial (not Phase III/IIIb or definitive Phase II/III) and does not have a time-to-event efficacy endpoint. | 待处理 |
| Long-term prevention of hereditary angioedema attacks with lanadelumab in adolescents.Ann Allergy Asthma Immunol | PMID 39128590无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial.Ann Am Thorac Soc | PMID 39141673无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Characterization and natural history of patients with LMNA-related dilated cardiomyopathy in the phase 3 REALM-DCM trial.ESC Heart Fail | PMID 39145700PMC11631308 | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial.J Clin Oncol | PMID 39151115PMC11608591 | 2024-Dec | 0.96 | 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 | 待处理 |
| Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP.J Allergy Clin Immunol | PMID 39151476无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| A phase 3, randomized, double-blind, sham-controlled trial of SI-6603 (condoliase) in patients with radicular leg pain associated with lumbar disc herniation.Spine J | PMID 39168360无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.J Clin Oncol | PMID 39173098PMC11608596 | 2024-Dec | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 已完成 |
| A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement.J Am Acad Dermatol | PMID 39208985无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE).J Allergy Clin Immunol Pract | PMID 39209068无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study.J Heart Lung Transplant | PMID 39222737无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。 | PMID 39241959无 PMCID | 2024-Dec | 1.00 | 命中用户提供的消化道肿瘤阳性参考集。 | 无 KM 图 |
| Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。 | PMID 39241963无 PMCID | 2024-Dec | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 无 KM 图 |
| Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial.Eur Urol | PMID 39242323PMC12888041 | 2024-Dec | 0.96 | 属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。 | 待处理 |
| Cost per responder analysis of abrocitinib versus dupilumab in moderate to severe atopic dermatitis.Ital J Dermatol Venerol | PMID 39250163无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial.Eur Urol | PMID 39266383无 PMCID | 2024-Dec | 0.90 | The record describes a Phase III randomized trial in prostate cancer, but it compares two non-drug interventions (prostatectomy vs. stereotactic radiotherapy) and does not report a time-to-event efficacy endpoint; primary outcomes are patient-reported quality of life metrics. | 待处理 |
| Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trial.Br J Haematol | PMID 39267281无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| A Streamlined Strategy for Basophil Activation Testing in a Multicenter Phase III Clinical Trial.J Allergy Clin Immunol Pract | PMID 39284563无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。 | PMID 39289145无 PMCID | 2024-Dec | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 无 KM 图 |
| Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.Ann Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。 | PMID 39306585无 PMCID | 2024-Dec | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 无 KM 图 |
| 5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1).J Hepatobiliary Pancreat Sci疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。 | PMID 39318258无 PMCID | 2024-Dec | 0.98 | 原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。 | 无 KM 图 |
| Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial.Sleep Med | PMID 39321628无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.Aliment Pharmacol Ther | PMID 39327857PMC11599788 | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| Patiromer for Heart Failure Medication Optimization in Patients With Current or Past Hyperkalemia: DIAMOND Subanalysis.JACC Heart Fail | PMID 39340493无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |
| DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China.J Plast Reconstr Aesthet Surg | PMID 39353286无 PMCID | 2024-Dec | 0.98 | 未发现恶性肿瘤人群证据。 | 待处理 |